Nyumbani › Leukemia ya Biphenotypic ya Ghafla › Michigan
Majaribio ya kliniki ya Leukemia ya Biphenotypic ya Ghafla katika jimbo la Michigan
Masomo 4 ya Leukemia ya Biphenotypic ya Ghafla yanatafuta washiriki katika vituo vya jimbo la Michigan.
Miji katika jimbo la Michigan
Maandishi rasmi ya utafiti (Kiingereza)
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- C S Mott Children's Hospital, Ann Arbor
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Bronson Methodist Hospital, Kalamazoo
InaajiriHatua 2
365 Days · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06317662Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- na zaidi ya 2
InaajiriHatua 3
365 Days – 25 Years · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- na zaidi ya 2
InaajiriHatua 1/2
Hadi umri 22 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT04726241Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- C.S. Mott Children's Hospital, Ann Arbor
InaajiriHatua 1
Umri 1 hadi 21 · Jinsia zote · Imesasishwa 6 Des 2024 · NCT05476770Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.